Pluristem Therapeutics (PSTI) Joins Both the TA-75 and TA-100 Indexes on the Tel Aviv Stock Exchange  
12/10/2012 9:16:41 AM

HAIFA, Israel, Dec. 10, 2012 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today it has been informed by the Tel Aviv Stock Exchange (TASE) that its shares are now listed in both the Tel-Aviv-75 (TA-75) and the Tel Aviv-100 (TA-100) Index effective December 16, 2012. The TA-100 index tracks the top 100 companies listed on TASE weighted by market capitalization.